[二元代谢手术到2025年]
Thomas P Hüttl1,2, Peter Stauch3,4
1Abteilung für Allgemein- und Viszeralchirurgie, Dr. Lubos Kliniken Bogenhausen/Pasing, Denninger Str. 44, 81679, München, Deutschland. chirurgie@lubos-kliniken.de.
Innere Medizin (Heidelberg, Germany)
|April 28, 2025
概括
腹/代谢手术为病态肥胖症,2型糖尿病 (DMT2) 和相关疾病提供了有效的治疗方法. 综合后续护理对于持续的积极结果和管理潜在并发症至关重要.
科学领域:
- 代谢手术是一种代谢手术.
- 减肥手术 减肥手术是什么
- 治疗肥胖症的治疗方法
背景情况:
- 手术干预是治疗致病性肥胖及其并发症的关键.
- 减肥/代谢手术不仅仅是减肥,还包括代谢控制.
- 这些程序对2型糖尿病和其他与肥胖相关的疾病非常有效.
研究的目的:
- 审查减肥/代谢手术的范围和机制.
- 突出各种可用的外科手术和内镜手术.
- 强调多学科后续护理的重要性.
主要方法:
- 审查当前的减肥/代谢外科和内镜手术程序.
- 讨论作用机制 (限制,吸收不良等).
- 长期患者随访的基本组成部分概述.
主要成果:
- 腹/代谢手术是2型糖尿病 (DMT2) 肥胖患者最有效的治疗方法.
- 代谢效应在手术后的早期观察到,并且可以发生在非肥胖个体中.
- 有各种不同的程序,包括袖子胃切除术,胃旁路术和内镜选择.
结论:
- 减肥/代谢手术为肥胖和相关疾病提供全面的治疗.
- 目前正在进行的研究探讨了除了限制和吸收不良之外的各种机制.
- 结构化,多学科的后续对长期成功和管理并发症至关重要.
相关概念视频
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...